NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Clinical trials for NON-MUSCLE INVASIVE BLADDER NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER NEOPLASMS trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder implant aims to keep cancer from coming back
Disease control Recruiting nowThis study is testing a new drug delivery system called TAR-210, which is a small implant placed in the bladder to slowly release a targeted cancer drug. It is being compared to standard liquid chemotherapy placed directly into the bladder. The goal is to see which treatment is b…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New bladder implant aims to zap cancer from the inside
Disease control Recruiting nowThis study is testing a new device called TAR-210, which is placed in the bladder to slowly release a cancer drug called erdafitinib. The goal is to treat bladder cancer directly at the site, potentially controlling the disease while reducing side effects that can happen when the…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Personalized vaccine joins fight against bladder cancer recurrence
Disease control Recruiting nowThis study is testing whether adding a new personalized cancer vaccine called V940 to the standard BCG treatment helps people with high-risk bladder cancer stay cancer-free longer. Researchers will compare the combination of V940 plus BCG against BCG treatment alone in about 308 …
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New bladder cancer injection enters first human safety tests
Disease control Recruiting nowThis early-stage trial is testing a new drug called belzupacap sarotalocan (AU-011) for bladder cancer that hasn't spread into the muscle wall. Researchers will inject the drug directly into tumors during a standard bladder procedure to see if it's safe and practical to use. The …
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Tracking new bladder cancer treatment in everyday practice
Disease control Recruiting nowThis study follows 150 people with early-stage bladder cancer who have already started treatment with TAR-200 in real-world medical settings. The main goal is to see how long patients stay cancer-free after starting this treatment and to monitor how the treatment is actually used…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
New bladder implant aims to stop Cancer's return
Disease control Recruiting nowThis study is testing a new, long-acting drug implant called TAR-210 that is placed directly into the bladder. It is for people with a specific type of high-risk bladder cancer that has come back after standard BCG treatment. The goal is to see if this new implant works better an…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC